We’re excited to share that the iPregnostic Clinical Trial is now underway. This study focuses on pregnant women in their first trimester and aims to validate the use of our MaiRa test for detecting preeclampsia and other obstetric conditions at an early stage.
The trial has been approved by the Spanish Agency of Medicines and Medical Devices (AEMPS) and will be conducted in 11 hospitals across Spain. With a goal of enrolling 7,473 participants, this study is a big step forward in improving prenatal care and helping doctors identify risks before symptoms appear.
If you’d like to learn more or are interested in participating, reach out to us at ipregnostic.study@ipremom.com
